The remedē® System is a product of ZOLL Respicardia, a leader in technologies that address the unmet needs of people with Central Sleep Apnea. ZOLL Respicardia is dedicated to improving quality of life for patients living with CSA.

CSA is a serious breathing disorder that disrupts the normal breathing pattern and negatively affects quality of life and overall health. The remedē® System is an FDA approved, non-mask therapy designed to treat moderate to severe Central Sleep Apnea (CSA) in adult patients.

You should not have the remedē System implanted if you have an infection and you will not be able to have diathermy (special heat therapies) after implantation. As with any surgically implanted device, there are risks related to the surgical procedure itself which may include, but are not limited to, pain, swelling, and infection. Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the remedē System.